Email
Print
IV Therapy & Vein Access Devices Market - Forecast(2024 - 2030)
IV Therapy & Vein Access Devices Market Overview
IV Therapy & Vein Access Devices Market size is estimated to reach $1,081 million by 2027, growing at a CAGR of 4.8% during the forecast period 2022-2027. Intravenous (IV) therapy is one of the
most typically utilized medical treatments. It is performed in places like emergency
rooms, hospitals, clinics, nursing homes and even at homes. IV treatment
is utilized for an assortment of purposes, inclusive of rehydrating dehydrated individuals.
Dehydration can be rapid and severe in patients with acute vomiting and/or diarrhoea,
specifically in children. IV treatment replaces and transfers fluids and
electrolytes, giving the digestive system a break. Medicine, nutrition, blood and a buffer solution are all delivered straight into the vein with intravenous
therapy. When compared to oral medication, IV treatment provides a speedier
immune system response and alleviation from chronic conditions. IV therapy includes an infusion pump that regulates the volume of the medicine to be supplied to the
body and can be effortlessly monitored. Intravenous therapy can be applied for fluid
replacement, electrolyte imbalances correction, pharmaceutical delivery and
blood transfusions. Intravenous therapy is a technique in which a cannula is
placed inside a vein to offer venous access. IV
therapy is typically categorized as colloids and crystalloids. Crystalloid
solutions include solutes like electrolytes or
dextrose, which are effortlessly blended and dissolvable in the solution.
Intravenous vancomycin can be securely and cost-efficiently administered in the
deep vessels of the upper arm. IV therapy & vein access devices are used for
fluid infusion, blood transfusion, administration of drugs, venous pressure
monitoring and blood sampling. When administered intravenously, fosaprepitant, a prodrug of aprepitant, is transformed to aprepitant within 30 minutes.
The rising prevalence of chronic diseases among people, the surging application of intravenous vancomycin and
the growing technological advancement in the healthcare sector including the IV Therapy & Vein Access Devices industry are set to drive the
IV Therapy & Vein Access Devices Market Report Coverage
The “IV
Therapy & Vein Access Devices Market Report - Forecast (2022-2027)" by Industry ARC, covers an in-depth analysis of the following segments
in the IV Therapy & Vein Access Devices Market.
Key Takeaways
- Geographically, North America (IV Therapy & Vein Access Devices Market) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of chronic diseases and the rise in the geriatric population in the North American region.
- IV Therapy & Vein Access Devices Market growth is being driven by the heightening count of road accidents, surging administration of medicines or other medical therapy like blood products or electrolytes to fix electrolyte imbalances by way of intravenous therapy and rising instances of trauma cases. However, the complexities connected with intravenous therapy and the dearth of experienced and skilled professionals are some of the major factors hampering the growth of IV Therapy & Vein Access Devices Market.
- IV Therapy & Vein Access Devices Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the IV Therapy & Vein Access Devices Market Report.
IV Therapy & Vein Access Devices Market: Market Share (%) By Region, 2021
For More Details on This Report - Request for Sample
IV Therapy & Vein Access Devices Market Segment Analysis - By Type
IV Therapy & Vein Access Devices Market Segment Analysis - By End User
The IV Therapy & Vein Access Devices Market based on end user can be further segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. The Hospitals & Clinics Segment held the largest IV Therapy & Vein Access Devices market share in 2021. This growth is owing to the effortless accessibility of progressive technology and skilled professionals in hospitals. Patients therefore mostly prefer hospitals for their treatment. A hospital is a healthcare facility that treats patients with medical and surgical procedures. Surgery, oncology, obstetrics, and pediatrics are just a few of the departments found in most hospitals. In hospitals, intravenous (IV) therapy is routinely utilized to provide medicines and other treatments to patients. Crystalloid solutions are isotonic plasma volume expanders that include electrolytes. They can boost the circulatory volume without changing the chemical balance in the vascular spaces. Moreover, owing to the rising development in the healthcare industry, the number of hospitals has increased which in turn escalates the demand for nervous treatments in hospitals which is further propelling the growth of the Hospitals segment.
Furthermore, the Ambulatory Surgical Centers segment is estimated to grow with the fastest CAGR of 5.9% during the forecast period 2022-2027 owing to ambulatory surgical centers being cost-effective, highly efficient, and offering a convenient setting for IV therapy procedures. In ambulatory surgical centers, the number of surgical procedures is more, which is further spiraling the demand for IV Therapy & Vein Access Devices. Here, doctors are mostly specialized in surgical procedures and therefore patients also prefer to visit ambulatory surgical centers for their treatment. Colloid solutions utilized in intravenous therapy belong to a principal group of volume expanders, and can be applied for intravenous fluid replacement. Increased adoption of vein access devices in ambulatory surgical centers as well as fast-improving global healthcare infrastructure, are further fueling the growth of this segment.
IV Therapy & Vein Access Devices Market Segment Analysis - By Geography
The IV Therapy & Vein Access Devices Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (IV Therapy & Vein Access Devices Market) held the largest IV Therapy & Vein Access Devices market share with 49% of the overall market in 2021. The growth of this region is owing to the increasing predominance of incessant ailments attributed to the rise in the geriatric population, well-established healthcare systems and an increase in awareness among the population towards timely diagnosis and treatment of diseases. Fosaprepitant is a prescription medication utilized to avert nausea and vomiting brought about by chemotherapy. As per American Chemical Society (ACS), vancomycin is an amphoteric glycopeptide antibiotic generated by the soil bacterium Amycolatopsis orientalis. As per the Centers for Disease Control And Prevention (CDC) in 2020, around 600,000 women in the U.S. have a hysterectomy each year. As per the 2019 updates of Health grades, Operating Company Inc., it was recorded that around 500,000 women in the U.S. have a hysterectomy each year; around 460,000 U.S. residents have a cholecystectomy and 1.3 million pregnant women look for C-section in the U.S. All these procedures require intravenous therapy for the administration of medications and fluids and this is further propelling the growth of the IV Therapy & Vein Access Devices Market in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the surging demand for progressive technologies in the Asia-Pacific region. On the basis of Standards, the requirement to administer vancomycin (pH 3.9) – the most typical intravenous treatment for (MRSA) methicillin resistant staphylococcus aureus – is frequently regarded an automatic indication for central venous access by vascular access specialists. The increasing predominance of kidney ailments and diabetes is further fueling the progress of the IV Therapy & Vein Access Devices Market in the Asia-Pacific region.
IV Therapy & Vein Access Devices Market Drivers
The
Rising Prevalence of Chronic Disorders among People Gives Rise to the Demand For
IV therapy & Vein Access Devices that has Readily Assisted the Growth of the
As per the World Health Organization (WHO), in 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly brought about by diabetes. The prevalence of chronic diseases is increasing owing to the rapid aging of the population. As per the Centers for Disease Control and Prevention (CDC), hypertension, or high blood pressure, is a leading risk factor for cardiovascular disease (CVD) and brings about over 10 million deaths globally every year. Chronic disease is a concern to rural healthcare systems and rural residents owing to its impact on quality of life, mortality, and healthcare costs. Chronic diseases and conditions are on the rise worldwide. An aging population and changes in societal behavior are contributing to a steady increase in these common and costly long-term health problems. The middle class is growing and with urbanization accelerating and people are adopting a more sedentary lifestyle. This is pushing obesity rates and cases of diseases such as diabetes upward. Owing to the rising number of chronic diseases, the use of IV therapy & vein access devices is surging. IV therapy & vein access devices are beneficial for numerous reasons like the ease of administration. IV therapy is an easy and convenient option if the patient does not want to visit the hospital. A classic IV Therapy & Vein Access Devices Industry application is in the healthcare sector. Fosaprepitant may rarely bring about serious allergic reactions (like flushing, redness, or trouble breathing) while it is being provided. The rising prevalence of chronic disorders among people giving rise to the demand for IV therapy & vein access devices is therefore fueling the growth of the IV Therapy & Vein Access Devices Market during the forecast period 2022-2027.
The Growing Advancement in Technology is Fueling the Growth of the IV Therapy & Vein Access Devices Industry
83% of medical patients in the U.S. accept some kind of IV therapy or infusion as of 2019. Technological advancements in the healthcare infrastructure give rise to growth in the IV Therapy & Vein Access Devices market. Additionally, different technological advancements in IV therapy and the development of innovative vein access devices, are acting as other growth-inducing factors. "A single intravenous dose of fosaprepitant 115 mg, a prodrug of aprepitant, is bioequivalent to oral aprepitant 125 mg". Currently, technological advances can contribute to safer practice and quality of intravenous therapy which further enhances the market growth. Other factors, such as increased consumer healthcare expenditures and major advances in medical infrastructure, particularly in developing nations, are estimated to propel the market growth. The use of central venous catheters (CVCs) for vascular access is now commonplace in an assortment of care settings. Technological advances related to CVCs have introduced a multitude of catheter designs that are available to users through numerous manufacturers. To initiate the appropriate procedures for care, nurses involved in the maintenance of central venous access devices are now challenged with having to be familiar with a large variety of central venous access devices. In the future, advancements in vein finder technology and IV therapies would increase their demand and would be preferred over other routes such as oral, enteral, and topical. The growing advancement in technology is therefore fueling the growth of the IV Therapy & Vein Access Devices Industry during the forecast period 2022-2027.
IV Therapy & Vein Access Devices Market Challenges
Lack of Skilled professionals in Healthcare Sector is Hampering the growth of the IV Therapy & Vein Access Devices Market
Globally, there is a critical shortage of skilled professionals in healthcare workers. India faces the problem of acute shortages and inequitable distributions of skilled health workers. In May 2019, as reported in the Times Of India, as per an investigation, 54% of health professionals in India do not have required qualifications. The healthcare sector is facing a shortage of digitally skilled labor as demand for health services increases and the sector adopts new technologies which further reduces their ability to handing the procedure of IV Therapy & Vein Access Devices technology. The shortage of skilled professionals is a major contributor to the ailing healthcare system in India. COVID-19 has also demonstrated that the healthcare capacity deployed towards the management of pandemics in urban and rural centers competes directly with the essential diagnostic, medical, interventional, and surgical care for other diseases like chronic diseases. These issues are hampering the growth of the IV Therapy & Vein Access Devices Market.
IV Therapy & Vein Access Devices Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the IV Therapy & Vein Access Devices Market. The top 10 companies in the IV Therapy & Vein Access Devices Market are:
- Access Vascular Inc.
- B. Braun Medical Inc.
- Medtronic
- Carefusion Corporation
- Fresenius Kabi AG
- Terumo Corporation
- Baxter International Inc.
- Smiths Medical
- Johnson and Johnson Pvt. Ltd.
- Hospira Inc.
Recent Developments
- In February 2022, Access Vascular, Inc. (AVI), entered a partnership with Healthcare Insights (HCIS) to build a value-based care program that can more broadly support hospital customers as they deploy the firm's groundbreaking biomaterial-based catheters to enhance vascular access to medical and economic outcomes. AVI is influencing decades of hospital administration, clinical and reimbursement knowledge from HCIS in the establishment of its outcome-based care program for hospitals in the U.S. The program aims attention on assisting acute care facilities for decreasing practice variation and standardizing procedural practice for enhanced outcomes and decreased costs connected with vascular access complexities like thrombosis, infections, replacements and readmissions.
- In September 2021, B. Braun Medical Inc. introduced its novel CARE SAFE IV Administration Sets with Optional AirStop component. CARE SAFE IV Sets are the first robust portfolio of IV administration sets in the U.S. market that are not prepared with polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP). In addition to decreasing patient exposure to toxic substances, CARESAFE IV Sets with Optional AirStop component also assist in safeguarding patients from the risks connected with air infusion and assists in averting the line from running dry.
- In April 2021, Medtronic revealed its Extended infusion set, the earliest set that can be worn to deliver insulin for up to seven days, in select European countries. Infusion sets are tubing that offer insulin to the body from a pump, and they normally require to be altered every few days. The Extended infusion set doubles the time a set can be used. This concludes the IV Therapy & Vein Access Devices Industry Outlook.
Relevant Reports
Infusion
Pump Market - Forecast(2022 - 2027)
Report Code - HCR 49498
Report Code - HCR 29389
Report Code - HCR 59140
For more Lifesciences and Healthcare Market reports, please click here